maleimide has been researched along with Colorectal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chantima, W; Dharakul, T; Jarussophon, S; Khantasup, K; Saiviroonporn, P | 1 |
Begent, RH; Casey, JL; Chaplin, LC; Green, AJ; Hope-Stone, LD; King, DJ; Napier, MP; Pedley, RB; Skelton, L; Weir, N; Yarranton, GT | 1 |
1 trial(s) available for maleimide and Colorectal Neoplasms
Article | Year |
---|---|
Tumour targeting of humanised cross-linked divalent-Fab' antibody fragments: a clinical phase I/II study.
Topics: Area Under Curve; Colorectal Neoplasms; Half-Life; Humans; Immunoglobulin Fab Fragments; Maleimides; Radioimmunotherapy; Radionuclide Imaging | 2002 |
1 other study(ies) available for maleimide and Colorectal Neoplasms
Article | Year |
---|---|
Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer.
Topics: Binding Sites; Cell Line, Tumor; Chelating Agents; Colorectal Neoplasms; Contrast Media; Dose-Response Relationship, Drug; Epithelial Cell Adhesion Molecule; Gadolinium; Gadolinium DTPA; HEK293 Cells; Humans; Immunoglobulin Fragments; Magnetic Resonance Imaging; Maleimides; Microscopy, Confocal; Protein Domains; Reproducibility of Results | 2018 |